Clinical Trial Update: A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 randomized study evaluating primary tumor radiotherapy for patients with malignant pleural effusion in stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Snippet

Sponsor: Guizhou Medical University | Conditions: Malignant Pleural Effusion, Nonsmall Cell Lung Cancer, Stage IV | Phase 2 | Status: UNKNOWN